ARENTFOX SCHIFF LLP

Lobbying for PINNACLE BIOLOGICS, INC. · Developer of complex critical care therapies for cancers

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $20,000.00 income · posted Oct 17, 2025

Lobbying activity 1

Medicare/Medicaid

Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.